NLM Logo

PCI-27483 MeSH Supplementary Concept Data 2025


MeSH Supplementary
PCI-27483
Unique ID
C000630842
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000630842
Entry Term(s)
(S)-2-(2-(5-(5-carbamimidoyl-1H-benzo(d)imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-(1,1'-biphenyl)-3-yl)acetamido)succinic acid
L-aspartic acid, N-(2-(5(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)-
N-((5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-3-biphenylyl)acetyl)-L-aspartic acid
Registry Numbers
6073LCU8U9
Heading Mapped to
Aspartic Acid / analogs & derivatives
*Benzamidines
*Benzimidazoles
*Phenols
*Sulfonamides
Frequency
1
Note
Factor VIIa Inhibitor
Source
Oncology. 2019;96(4):217-222.
Date of Entry
2019/05/01
Revision Date
2022/03/31
PCI-27483 Preferred
L-aspartic acid, N-(2-(5(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)- Broader
page delivered in 0.002s